RIGEL PHARMACEUTICALS INC (RIGL)
US7665596034 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -25.09M | -58.57M | -17.91M | -29.74M | -66.89M | |||
| Depreciation Amortization | 1.24M | 1.00M | 1.16M | 710.00K | 680.00K | |||
| Change In Working Capital | 9.52M | -29.05M | 9.72M | -30.32M | 16.66M | |||
| Interest Paid | 5.85M | 2.50M | 1.50M | 1.18M | 140.00K | |||
| Taxes Paid | N/A | N/A | 1.50M | 1.18M | 140.00K | |||
| Other non cash items | 8.59M | 12.87M | 12.91M | 7.18M | 8.04M | |||
| OPERATING CASH FLOW | -5.74M | -73.76M | 5.88M | -52.19M | -41.51M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -15.00M | -450.00K | -630.00K | -1.26M | -1.46M | |||
| Other Investing Activity | 10.70M | 73.23M | -79.41M | 48.73M | -22.20M | |||
| INVESTING CASH FLOW | -4.30M | 72.78M | -80.04M | 47.47M | -23.66M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 19.95M | 19.54M | 0.00 | 9.98M | 9.79M | |||
| Stock Issued/Repurchased | 1.05M | 2.12M | 4.78M | 2.60M | 1.58M | |||
| Other Financing Activity | -2.63M | -15.12M | 57.90M | N/A | N/A | |||
| FINANCING CASH FLOW | 18.37M | 6.55M | 62.68M | 12.57M | 11.37M | |||
| CHANGE IN CASH | 8.33M | 5.57M | -11.48M | 7.85M | -53.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.74M | -73.76M | 5.88M | -52.19M | -41.51M | |||
| Capital Expenditure | -15.00M | -450.00K | -630.00K | -1.26M | -1.46M | |||
| FREE CASH FLOW | -20.74M | -74.21M | 5.25M | -53.45M | -42.97M | |||
All data in USD